Global Gastric Cancer Market Analysis 2016 - Forecast to 2022

  • ID: 3845821
  • Report
  • Region: Global
  • 131 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Gastric Cancer". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
3.5 Pipeline Analysis

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Gastric Cancer Market by Testing Type
5.1 Introduction
5.2 Chest X-Ray
5.3 Computed Tomography (CT or CAT) Scan
5.4 Helicobacer Pylori
5.5 Imaging Tests
5.6 Laparoscopy
5.7 Magnetic Resonance Imaging (MRI) Scan
5.8 Positron Emission Tomography (PET) Scan
5.9 Upper Gastrointestinal (GI) Series

6 Gastric Cancer Market by Drug Class
6.1 Introduction
6.2 Docetaxel
6.3 Doxorubicin Hydrochloride
6.4 Fluorouracil
6.5 Imatinib
6.6 Mitomycin C
6.7 Sunitinib
6.8 Trastuzumab

7 Gastric Cancer Market by Treatment Type
7.1 Introduction
7.2 Adjuvant chemotherapy
7.3 Chemo Therapy
7.4 Radiation therapy
7.5 Surgery
7.6 Targeted drugs therapy

8 Gastric Cancer Market by Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Eli Lilly and Company
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 AstraZeneca Plc.
10.3 Biogen idec
10.4 Bristol Myers Squibb
10.5 F Hoffmann-La Roche
10.6 Genentech, Inc
10.7 GlaxoSmithKline
10.8 Hoffmann-la Roche inc.
10.9 Immunogen
10.10 Merck KGaA
10.11 Novartis AG
10.12 Oncolytics
10.13 Otsuka Pharmaceutical
10.14 Pacific edge diagnostics NZ
10.15 Roche Holdings AG
10.16 Sanofi-Aventis
10.17 Zova biotherapeutics Inc.

10 Appendix
11 Disclaimer

List of Tables
Table 1 Global Gastric Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Gastric Cancer Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 3 Global Chest X-Ray Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Chest X-Ray Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 5 Global Chest X-Ray Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 6 Global Computed Tomography (CT or CAT) Scan Market Analysis, by Region, 2013-2022 ($MN)
Table 7 Global Computed Tomography (CT or CAT) Scan Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 8 Global Computed Tomography (CT or CAT) Scan Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 9 Global Helicobacer Pylori Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Helicobacer Pylori Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 11 Global Helicobacer Pylori Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 12 Global Imaging Tests Market Analysis, by Region, 2013-2022 ($MN)
Table 13 Global Imaging Tests Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 14 Global Imaging Tests Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 15 Global Laparoscopy Market Analysis, by Region, 2013-2022 ($MN)
Table 16 Global Laparoscopy Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 17 Global Laparoscopy Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 18 Global Magnetic Resonance Imaging (MRI) Scan Market Analysis, by Region, 2013-2022 ($MN)
Table 19 Global Magnetic Resonance Imaging (MRI) Scan Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 20 Global Magnetic Resonance Imaging (MRI) Scan Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 21 Global Positron Emission Tomography (PET) Scan Market Analysis, by Region, 2013-2022 ($MN)
Table 22 Global Positron Emission Tomography (PET) Scan Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 23 Global Positron Emission Tomography (PET) Scan Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 24 Global Upper Gastrointestinal (GI) Series Market Analysis, by Region, 2013-2022 ($MN)
Table 25 Global Upper Gastrointestinal (GI) Series Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 26 Global Upper Gastrointestinal (GI) Series Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 27 Global Gastric Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 28 Global Gastric Cancer Market Analysis, by Drug class, 2013-2022 ($MN)
Table 29 Global Docetaxel Market Analysis, by Region, 2013-2022 ($MN)
Table 30 Global Docetaxel Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 31 Global Docetaxel Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 32 Global Doxorubicin Hydrochloride Market Analysis, by Region, 2013-2022 ($MN)
Table 33 Global Doxorubicin Hydrochloride Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 34 Global Doxorubicin Hydrochloride Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 35 Global Fluorouracil Market Analysis, by Region, 2013-2022 ($MN)
Table 36 Global Fluorouracil Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 37 Global Fluorouracil Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 38 Global Imatinib Market Analysis, by Region, 2013-2022 ($MN)
Table 39 Global Imatinib Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 40 Global Imatinib Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 41 Global Mitomycin C Market Analysis, by Region, 2013-2022 ($MN)
Table 42 Global Mitomycin C Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 43 Global Mitomycin C Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 44 Global Sunitinib Market Analysis, by Region, 2013-2022 ($MN)
Table 45 Global Sunitinib Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 46 Global Sunitinib Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 47 Global Trastuzumab Market Analysis, by Region, 2013-2022 ($MN)
Table 48 Global Trastuzumab Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 49 Global Trastuzumab Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 50 Global Gastric Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 51 Global Gastric Cancer Market Analysis, by Treatment Type, 2013-2022 ($MN)
Table 52 Global Chemo Therapy Market Analysis, by Region, 2013-2022 ($MN)
Table 53 Global Chemo Therapy Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 54 Global Chemo Therapy Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 55 Global Chemo Therapy Market Analysis, by Region, 2013-2022 ($MN)
Table 56 Global Chemo Therapy Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 57 Global Chemo Therapy Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 58 Global Radiation therapy Market Analysis, by Region, 2013-2022 ($MN)
Table 59 Global Radiation therapy Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 60 Global Radiation therapy Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 61 Global Surgery Market Analysis, by Region, 2013-2022 ($MN)
Table 62 Global Surgery Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 63 Global Surgery Market Analysis, by Drug Class, 2013-2022 ($MN)
Table 64 Global Targeted drugs therapy Market Analysis, by Region, 2013-2022 ($MN)
Table 65 Global Targeted drugs therapy Market Analysis, by Testing Type, 2013-2022 ($MN)
Table 66 Global Targeted drugs therapy Market Analysis, by Drug Class, 2013-2022 ($MN)

Note: Regional tables are presented in the similar manner as the above
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll